Chinese Traditional and Herbal Drugs
|
2025, 56(17): 6272-6277
Clinical observation of Bufei Huoxue Capsule combined with 2HRZE/4HR regimen in treatment of newly diagnosed pulmonary tuberculosis in elderly patients and its effect on peripheral blood cell subsets
Full
LIAN Taomei1, CHEN Ying1, CUI Xiaohua1, LI Kunying1, LIU Xiao1
Affiliations
1 Henan Provincial Chest Hospital, Chest Hospital Affiliated to Zhengzhou University, Zhengzhou 450000, China
About Author:
河南省医学科技攻关项目 (LHGJ20230113)
doi: 10.7501/j.issn.0253-2670.2025.17.017
Outline
Objective To observe the clinical efficacy of Bufei Huoxue Capsule (补肺活血胶囊) combined with the 2HRZE/4HR regimen in treating elderly patients with newly diagnosed pulmonary tuberculosis (PTB) presenting with deficiency of lung-yin and blood stasis syndrome, and to assess its impact on peripheral blood T-cell subsets. Methods A total of 206 eligible elderly patients with newly diagnosed PTB (deficiency of lung-yin and blood stasis syndrome) were enrolled and randomly divided into the control group (n = 103) and the observation group (n = 103). The control group received the standard 2HRZE/4HR anti-tuberculosis regimen, while the observation group received Bufei Huoxue Capsule plus the 2HRZE/4HR regimen. Both groups were treated continuously for six months. At the end of the treatment course, the following outcomes were compared: total effective rate, sputum smear conversion rate, lesion absorption effective rate, traditional Chinese medicine (TCM) symptom scores, changes in peripheral blood T-lymphocyte subsets (CD3+、CD4+、CD8+、CD4+/CD8+ ratio) before and after treatment, and incidence of adverse reactions. Results A total of 22 patients discontinued the study (11 per group). The observation group exhibited a significantly higher overall response rate (93.48% vs 83.69%, P < 0.05). After treatment, sputum smear conversion rates showed no significant difference between groups (P > 0.05). The lesion absorption effective rate of the observation group was significantly higher in the observation group (90.22% vs 75.00%, P < 0.05). Both groups showed reduced TCM symptom scores post-treatment (P < 0.05), with lower scores in the observation group (P < 0.05). After treatment, the levels of CD3+, CD4+, and CD4+/CD8+ in both groups increased compared with those before treatment, and the level of CD8+ decreased compared with that before treatment (P < 0.05). Moreover, the levels of CD3+, CD4+, and CD4+/CD8+ in the observation group were higher than those in the control group, and the level of CD8+ was lower than that in the control group (P < 0.05). No significant difference in adverse reaction incidence was observed between groups. Conclusion The efficacy of Bufei Huoxue Capsule combined with the 2HRZE/4HR regimen demonstrates superior efficacy over the 2HRZE/4HR regimen alone in treating elderly patients with newly diagnosed PTB. The integrated approach alleviates clinical symptoms, promotes lesion absorption, enhances immune function, and improves overall clinical outcomes, supporting the significant therapeutic value of combining traditional Chinese and Western medicine for PTB management.
elderly pulmonary tuberculosis
/
Bufei Huoxue Capsule
/
immune function
/
peripheral blood T lymphocytes
/
deficiency of lung-yin and blood stasis syndrome
廉桃梅, 陈瑛, 崔晓华, 李坤营, 刘笑.
补肺活血胶囊联合2HRZE/4HR方案治疗初治老年肺结核的临床观察及对外周血细胞亚群的影响.
中草药,
2025
, 56
(17)
: 6272
-6277
.
DOI: 10.7501/j.issn.0253-2670.2025.17.017
LIAN Taomei, CHEN Ying, CUI Xiaohua, LI Kunying, LIU Xiao.
Clinical observation of Bufei Huoxue Capsule combined with 2HRZE/4HR regimen in treatment of newly diagnosed pulmonary tuberculosis in elderly patients and its effect on peripheral blood cell subsets[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(17)
: 6272
-6277
.
DOI: 10.7501/j.issn.0253-2670.2025.17.017
Year 2025 volume 56 Issue 17
37
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.17.017
- Receive Date:2025-03-10
- Online Date:2026-11-12